Kevin Haigis has assumed the new position of Chief Scientific Officer

Kevin Haigis SOG_3086_20.jpg

As part of the leadership transition at Dana-Farber Cancer Institute, Kevin Haigis has assumed the position of Chief Scientific Officer. Kevin joined Dana-Farber earlier this year as Chief Research Officer, where he has overseen the operation of Dana-Farber’s research program, planning, and implementing our overall scientific strategy through the difficult period of the COVID-19 pandemic.

https://www.dana-farber.org/about-us/leadership/